{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:12:11Z","timestamp":1793059931493,"version":"4.5.0"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>In immunocompromised patients the Hepatitis E Virus (HEV) can lead to severe liver injury and possible liver failure. This case report describes a patient with acute myeloid leukemia in urgent need of allogeneic hematopoietic stem cell transplantation (HSCT), having symptomatic HEV infection. Prior to allogeneic HSCT, therapy with ribavirin was initiated. Urgent allogeneic HSCT was successfully performed despite persistence of HEV, with continuous ribavirin treatment during transplantation. Data regarding management of patients with HEV infection in need for HSCT is scarce. This case illustrates the feasibility of HSCT in patients with ongoing HEV-infection under continuous therapy with ribavirin.<\/jats:p>","DOI":"10.3389\/fonc.2026.1842139","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:55:28Z","timestamp":1782921328000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia and hepatitis E"],"prefix":"10.3389","volume":"16","author":[{"given":"Johanna","family":"Lepek","sequence":"first","affiliation":[{"name":"Department of Hematology, Oncology, Stem Cell Transplantation and Cellular Therapy, Knappschaft Kliniken Universit\u00e4tsklinikum Bochum, Ruhr University","place":["Bochum, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Lugnier","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, Stem Cell Transplantation and Cellular Therapy, Knappschaft Kliniken Universit\u00e4tsklinikum Bochum, Ruhr University","place":["Bochum, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"von Lilienfeld-Toal","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, Stem Cell Transplantation and Cellular Therapy, Knappschaft Kliniken Universit\u00e4tsklinikum Bochum, Ruhr University","place":["Bochum, Germany"]},{"name":"Institute for Diversity Medicine, Ruhr University Bochum","place":["Bochum, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Witkowsi","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, St. Josef Hospital, Ruhr University Bochum","place":["Bochum, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"G\u00f6tze","sequence":"additional","affiliation":[{"name":"Department of Medicine, Knappschaft Kliniken Universit\u00e4tsklinikum Bochum, Ruhr University","place":["Bochum, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Canbay","sequence":"additional","affiliation":[{"name":"Department of Medicine, Knappschaft Kliniken Universit\u00e4tsklinikum Bochum, Ruhr University","place":["Bochum, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Schroers","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, Stem Cell Transplantation and Cellular Therapy, Knappschaft Kliniken Universit\u00e4tsklinikum Bochum, Ruhr University","place":["Bochum, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mika","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, Stem Cell Transplantation and Cellular Therapy, Knappschaft Kliniken Universit\u00e4tsklinikum Bochum, Ruhr University","place":["Bochum, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrgastro.2017.150","article-title":"Hepatitis E virus: advances and challenges","volume":"15","author":"Nimgaonkar","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2024.06.020","article-title":"Hepatitis E virus infection in immunosuppressed patients and its clinical manifestations","volume":"57","author":"Kupke","year":"2025","journal-title":"Dig Liver Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(25)00049-3","article-title":"Updated recommendations for the management of hepatitis B, C, and E virus infections in patients with haematological Malignancies and those undergoing haematopoietic cell transplantation: recommendations from the 9th European Conference on Infections in Leukaemia (ECIL-9)","volume":"12","author":"Mikulska","year":"2025","journal-title":"Lancet Haematol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2019.08.002","article-title":"Hepatitis E virus in hematopoietic stem cell transplant recipients: A systematic review","volume":"119","author":"Cruz","year":"2019","journal-title":"J Clin Virol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614359","article-title":"Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"375\u201387","DOI":"10.1016\/j.jtct.2025.11.015","article-title":"Tailoring intensity: A perspective on thiotepa, busulfan, and fludarabine (TBF) conditioning for acute leukemias and myeloproliferative neoplasms","volume":"32","author":"Abdel Rahman","year":"2026","journal-title":"Transplant Cell Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.227199","article-title":"Allogeneic hematopoietic stem cell transplantation for primary central nervous system lymphoma","volume":"105","author":"Mika","year":"2020","journal-title":"Haematologica"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.03.012","article-title":"Hepatitis E virus infection in an Italian cohort of hematopoietic stem cell transplantation recipients: Seroprevalence and infection","volume":"26","author":"Furfaro","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/v11070622","article-title":"Hepatitis E and allogeneic hematopoietic stem cell transplantation: A French nationwide SFGM-TC retrospective study","volume":"11","author":"Xhaard","year":"2019","journal-title":"Viruses"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01497-2","article-title":"HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working Party","volume":"57","author":"Mikulska","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2015.00039","article-title":"Hepatitis E: An underdiagnosed, emerging infection in nonendemic regions","volume":"3","author":"Keukeleire","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0823-7","article-title":"Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients","volume":"55","author":"Swartling","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-0593-1","article-title":"The histologic presentation of hepatitis E reflects patients' immune status and pre-existing liver condition","volume":"34","author":"Lenggenhager","year":"2021","journal-title":"Mod Pathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13432","article-title":"Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection","volume":"28","author":"Mulder","year":"2021","journal-title":"J Viral Hepat"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13825","article-title":"Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancer","volume":"44","author":"Economides","year":"2016","journal-title":"Alimentary Pharmacol Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408921","article-title":"An interferon-free antiviral regimen for HCV after liver transplantation","volume":"371","author":"Kwo","year":"2014","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-019-02725-x","article-title":"Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort","volume":"75","author":"Barrail-Tran","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1218654","article-title":"Antiviral activity of zinc against hepatitis viruses: current status and future prospects","volume":"14","author":"Kumar","year":"2023","journal-title":"Front Microbiol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1842139\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:55:28Z","timestamp":1782921328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1842139\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":18,"alternative-id":["10.3389\/fonc.2026.1842139"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1842139","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"1842139"}}